News and Analysis

Researchers have developed a protein-like polymer (PLP) that shows promise in treating Huntington’s Disease (HD) by inhibiting toxic protein binding in the disease’s models. The polymer prevented mitochondrial autophagy, showed high stability and bioactivity, and displayed therapeutic potential superior to traditional peptides. The technology may be broadened to target complex protein interactions, thereby offering a promising therapeutic approach for neurodegenerative disorders.